menu
    • menu

    Company profile for Benitec Biopharma

    NEW Drugs in Dev: 2
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Benitec is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for the goal of providing sustained, long-lasting silencing of disease-causing genes from a single administration. We believe our technology has the potential to provide a “one shot” cure for a wide range of diseases that are currently addressed by strict ongoing treatment regimens o...
    Benitec is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for the goal of providing sustained, long-lasting silencing of disease-causing genes from a single administration. We believe our technology has the potential to provide a “one shot” cure for a wide range of diseases that are currently addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. At Benitec we are using this technology, called DNA-directed RNA interference, or ddRNAi, to develop product candidates in chronic.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Benitec BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3940 Trust Way Hayward, CA. 94545
    Telephone
    Telephone
    +61 (0)3 8692-7222
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://benitec.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/benitecbiopharma-ltd/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/BenitecLtd

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Benitec Hosts BB-301 Forum at 2026 MDA Conference
    Benitec Hosts BB-301 Forum at 2026 MDA Conference

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3252609/0/en/Benitec-Biopharma-to-Host-Industry-Forum-Breakfast-Event-at-the-2026-Muscular-Dystrophy-Association-Clinical-and-Scientific-Conference-on-March-10-2026-Highlighting-Continued-Progr.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    Benitec Bio Reports Encouraging BB-301 Phase 1B/2A Results
    Benitec Bio Reports Encouraging BB-301 Phase 1B/2A Results

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3251690/0/en/Benitec-Biopharma-Announces-Positive-Interim-Phase-1b-2a-Results-for-High-Dose-BB-301-and-Continued-Durable-Improvements-for-Low-Dose-BB-301-Treatment-at-the-2026-Muscular-Dystroph.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    MDA Accepts Benitec's Late-Breaking BB-301 Abstract
    MDA Accepts Benitec's Late-Breaking BB-301 Abstract

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3242474/0/en/Benitec-Biopharma-Announces-Acceptance-of-Late-Breaking-Abstract-for-the-BB-301-Phase-1b-2a-Clinical-Treatment-Study-at-the-Muscular-Dystrophy-Association-Clinical-Scientific-Confe.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    Benitec Bio Unveils Q2 2026 Financials And Operational Update
    Benitec Bio Unveils Q2 2026 Financials And Operational Update

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3237200/0/en/Benitec-Biopharma-Releases-Second-Quarter-2026-Financial-Results-and-Provides-Operational-Update.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share
    Benitec Bio Shows Strong, Durable Efficacy In BB-301 Ph 1B/2A
    Benitec Bio Shows Strong, Durable Efficacy In BB-301 Ph 1B/2A

    11 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/11/3216469/0/en/Benitec-Biopharma-Provides-Positive-Long-Term-Clinical-Study-Results-for-BB-301-Phase-1b-2a-Clinical-Trial-Demonstrating-Robust-Efficacy-and-Continued-Durability-of-Response.html

    GLOBENEWSWIRE
    11 Jan 2026
    Share Share
    Benitec Biopharma Announces Proposed Public Offering
    Benitec Biopharma Announces Proposed Public Offering

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3182031/0/en/Benitec-Biopharma-Inc-Announces-Proposed-Public-Offering.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search